Beijing's Oceanpine Capital closed its Fund II with $400 million for China-US investments in advanced technology, including biopharma companies.

This is the first time Oceanpine has sought funding from external LPs since its inception in Dec 2016, said the tech investor with offices in Beijing (headquarters), Hong Kong, and Silicon Valley. That year, the firm